RovenaRReaganMD

Obstetrics & Gynecology • San Diego, CA

Director and Principal Investigator - Women's Health Care Research Corp.

Join to view full profile

Dr. Reagan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Reagan's full profile

Already have an account?

Office
3750 Convoy St
Ste 311
San Diego, CA 92111
Phone+1 858-505-8567

Fax+1 858-505-0104

Summary

Women's Health Care: Rovena Reagan MD - Gynecology & Research

Rovena Reagan, MD - Gynecology & Clinical Research Trials in San Diego, California. Leading the search for better women's health care!

Education & Training

University of RochesterResidency, Obstetrics and Gynecology, 1984 - 1988
University of Oklahoma College of MedicineClass of 1984

Certifications & Licensure

NY State Medical License 1985 - Present
CA State Medical License 1988 - 2025
American Board of Obstetrics and Gynecology Obstetrics & Gynecology

Awards, Honors, & Recognition

Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Clinical Trials

Noninvasive Screening for Affected Pregnancies: Assay Development & Optimization in Affected Pregnancies Start of enrollment: 2009 Nov 01
Completed
Study of Contraceptive Efficacy & Safety of Phexxi™ (Previously Known as Amphora) Gel Compared to Conceptrol Vaginal Gel Start of enrollment: 2011 Apr 01
Completed
Phase 3
Specimen Collection From Pregnant Women at Increased Risk for Fetal Aneuploidy Start of enrollment: 2011 May 01
Recruiting
A Comparison of Estradiol Vaginal Cream to Estrace® Cream in 350 Postmenopausal Females With Atrophic Vaginitis Start of enrollment: 2014 Jun 01
Completed
Phase 3
Assess Safety and Efficacy of Vilaprisan in Patients With Uterine Fibroids Start of enrollment: 2015 Jun 01
Completed
Phase 2
E4 FREEDOM (Female Response Concerning Efficacy and Safety of Estetrol/Drospirenone as Oral Contraceptive in a Multicentric Study) - United States/Canada Study Start of enrollment: 2016 Aug 30
Completed
Phase 3
LIBERTY 1: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids Start of enrollment: 2017 Apr 26
Completed
Phase 3
Study Evaluating the Equivalence of GDC-229 and Metronidazole Vaginal Gel 0.75% in the Treatment of Bacterial Vaginosis Start of enrollment: 2017 Mar 10
Completed
Phase 3
Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral Contraceptive Start of enrollment: 2022 Feb 17
Terminated
Phase 3
Roles: Contact, Principal Investigator
Join now to see all

Research History

Principal InvestigatorPrincipal Investigator for Women's Health Care Research Corp. in San Diego, CA.2010 - Present

Professional Memberships

American College of Obstetricians and Gynecologists
Fellow

External Links

Websitehttp://whcresearch.com
Facebookhttps://www.facebook.com/womensclinicaltrials/